Correlation Between Quantum Genomics and ICeram SA
Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and ICeram SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and ICeram SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantum Genomics SA and ICeram SA, you can compare the effects of market volatilities on Quantum Genomics and ICeram SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of ICeram SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and ICeram SA.
Diversification Opportunities for Quantum Genomics and ICeram SA
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quantum and ICeram is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and ICeram SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICeram SA and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with ICeram SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICeram SA has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and ICeram SA go up and down completely randomly.
Pair Corralation between Quantum Genomics and ICeram SA
If you would invest 40.00 in ICeram SA on November 4, 2024 and sell it today you would earn a total of 0.00 from holding ICeram SA or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Quantum Genomics SA vs. ICeram SA
Performance |
| Timeline |
| Quantum Genomics |
| ICeram SA |
Quantum Genomics and ICeram SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quantum Genomics and ICeram SA
The main advantage of trading using opposite Quantum Genomics and ICeram SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, ICeram SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICeram SA will offset losses from the drop in ICeram SA's long position.| Quantum Genomics vs. Poxel SA | Quantum Genomics vs. Biophytis SA | Quantum Genomics vs. Gensight Biologics SA | Quantum Genomics vs. OSE Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |